Kidney function issues
Since the glucose-lowering effects of GIP have been shown to be impaired in patients with T2D, interest has focused on developing antidiabetic therapies based upon the actions of GLP-1 and GIP, the response to which remains intact
Hernantz A, Fernandez-Vivancos E, Montiel C, Vazquez JJ, Arnalich S: Changes in the intracellular homocysteine and glutathione content associated with aging
By activating GLP-1 receptors, semaglutide enhances insulin secretion when blood glucose levels are elevated, suppresses inappropriate glucagon release, slows gastric emptying, and reduces appetite
When using with insulin, administer as separate injections
Your genetic predispositions in key metabolic pathwaysincluding GLP-1 receptor sensitivity, appetite regulation genes, and fat distribution patternscontribute to this variation